Reply to 'HPV-associated oropharyngeal cancer - discussion points'

Matt Lechner^{1

2

3}, Jacklyn Liu⁴, Liam Masterson⁵, Tim R Fenton^{6

7}

Affiliations

¹ UCL Cancer Institute, University College London, London, UK. m.lechner@ucl.ac.uk.
² UCL Head & Neck Academic Centre, Division of Surgery and Interventional Science, University College London, London, UK. m.lechner@ucl.ac.uk.
³ Department of ENT, Barts Health NHS Trust, London, UK. m.lechner@ucl.ac.uk.
⁴ UCL Cancer Institute, University College London, London, UK.
⁵ Department of ENT, Cambridge University Hospitals NHS Trust, Cambridge, UK.
⁶ School of Biosciences, University of Kent, Canterbury, UK. t.fenton@soton.ac.uk.
⁷ School of Cancer Sciences, Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK. t.fenton@soton.ac.uk.

Comment

Matt Lechner et al. Nat Rev Clin Oncol. 2022 Jun.

. 2022 Jun;19(6):422-423.

doi: 10.1038/s41571-022-00627-z.

Matt Lechner^{1

2

3}, Jacklyn Liu⁴, Liam Masterson⁵, Tim R Fenton^{6

7}

¹ UCL Cancer Institute, University College London, London, UK. m.lechner@ucl.ac.uk.
² UCL Head & Neck Academic Centre, Division of Surgery and Interventional Science, University College London, London, UK. m.lechner@ucl.ac.uk.
³ Department of ENT, Barts Health NHS Trust, London, UK. m.lechner@ucl.ac.uk.
⁴ UCL Cancer Institute, University College London, London, UK.
⁵ Department of ENT, Cambridge University Hospitals NHS Trust, Cambridge, UK.
⁶ School of Biosciences, University of Kent, Canterbury, UK. t.fenton@soton.ac.uk.
⁷ School of Cancer Sciences, Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK. t.fenton@soton.ac.uk.

No abstract available

Comment on

HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.
Lechner M, Liu J, Masterson L, Fenton TR. Lechner M, et al. Nat Rev Clin Oncol. 2022 May;19(5):306-327. doi: 10.1038/s41571-022-00603-7. Epub 2022 Feb 1. Nat Rev Clin Oncol. 2022. PMID: 35105976 Free PMC article. Review.
HPV-associated oropharyngeal cancer - discussion points.
Goon P, Sudhoff H. Goon P, et al. Nat Rev Clin Oncol. 2022 Jun;19(6):422. doi: 10.1038/s41571-022-00626-0. Nat Rev Clin Oncol. 2022. PMID: 35351992 No abstract available.

1. Lechner, M., Liu, J., Masterson, L. & Fenton, T. R. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat. Rev. Clin. Oncol. https://doi.org/10.1038/s41571-022-00603-7 (2022). - DOI - PubMed - PMC
1. Goon, P. & Sudhoff, H. HPV-associated oropharyngeal cancer — discussion points. Nat. Rev. Clin. Oncol. https://doi.org/10.1038/s41571-022-00626-0 (2022). - DOI - PubMed
1. Masterson, L. et al. Deregulation of SYCP2 predicts early stage human papillomavirus-positive oropharyngeal carcinoma: a prospective whole transcriptome analysis. Cancer Sci. 106, 1568–1575 (2015). - DOI - PubMed - PMC
1. India Project Team of the International Cancer Genome Consortium. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat. Commun. 4, 2873 (2013). - DOI
1. Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576–582 (2015). - DOI